Robuta

https://www.jci.org/articles/view/126896
tyrosine kinase inhibitorsjcinotchinhibitionresistance
https://pubmed.ncbi.nlm.nih.gov/37984347/
EGFR-TKIs and ICIs are effective for treating recurrent NSCLC after surgery. Although adjuvant chemotherapy for completely resected pathological stage II to...
epidermal growth factorreceptor tyrosine kinaserelativeinhibitors